Lancet— 510(k) K262211
Substantially EquivalentTianjin Huahong Technology Co., Ltd.
FDA 510(k) clearance K262211 for Lancet, Substantially Equivalent on 2026-07-22. Applicant: Tianjin Huahong Technology Co., Ltd.. Device class: 2.
Summary
Tianjin Huahong Technology's Lancet is filed under QRL, multiple use blood lancets for single patient use only. The name is generic, and the record gives no model numbers or specs.
Class II, 21 CFR 878.4850. General and Plastic Surgery is both the classification panel and the review panel. It came in as a Special 510(k).
Tianjin Huahong filed from Tianjin, China. The decision came 22 calendar days after FDA received it (June 30 to July 22, 2026).
Clearance details
- Applicant
- Tianjin Huahong Technology Co., Ltd.
- Product code
- Product code QRL
- Device class
- Class 2
- Regulation
- 21 CFR 878.4850
- Advisory panel
- General, Plastic Surgery
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Tianjin, CN
Recent devices under product code QRL
view allMore clearances from Tianjin Huahong Technology Co., Ltd.
view allAdverse events under product code QRL
product code QRL- Other
- 1
- Total
- 1
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.